Trachoma Clinical Trial
Official title:
Developing and Evaluating Trachoma Diagnosis Training Tools in Preparation for the Trachoma Elimination Endgame: Investigating the Effectiveness, Acceptability and Feasibility of an App-based Versus Slide-based IGA Test for Trachoma Graders
Verified date | May 2022 |
Source | London School of Hygiene and Tropical Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Trachomatous inflammation-follicular (TF) is diagnosed by looking for clinical signs of infection of everted eyelids (conjunctivae) of children. The overall objective of this project is to investigate the effectiveness, acceptability and feasibility of an app-based versus slide-based IGA for trachoma graders. Fieldwork will take place during routine Tropical Data trainings. A non-inferiority randomised controlled trial design will be employed, with grader trainees randomised to app- or slide-based training, and then to app- or slide-based IGA testing. The training and IGA testing method will be compared with field IGA test score to determine which method best predicts passing the field IGA test.
Status | Terminated |
Enrollment | 32 |
Est. completion date | July 12, 2019 |
Est. primary completion date | July 12, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All trainers and trainee graders who attend selected Tropical Data training events will be eligible for inclusion in the study. Exclusion Criteria: - Individuals who do not provide consent are not eligible for inclusion in the study. |
Country | Name | City | State |
---|---|---|---|
Tanzania | Arusha region | Arusha |
Lead Sponsor | Collaborator |
---|---|
London School of Hygiene and Tropical Medicine | Federal Minstry of Health of Ethiopia, Jos University Teaching Hospital, National Institute for Medical Research, Tanzania, Pan American Health Organization, RTI International, Sightsavers, University College London Hospitals, World Health Organization |
Tanzania,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Classroom IGA success | The proportion of participants successfully passing (kappa =0.7) the app-based IGA. | 1 day | |
Primary | Classroom IGA success | The proportion of participants successfully passing (kappa =0.7) the slide-based IGA. | 1 day | |
Primary | Field IGA success | The correlation between classroom IGA score and field IGA score | 3 days | |
Primary | Field IGA success | The proportion of participants who successfully pass the classroom IGA test (kappa =0.7) who also successfully pass the field-based IGA test (kappa =0.7) | 3 days | |
Secondary | Trainee characteristics | Association (reported as proportions, unadjusted and adjusted odds ratios) between trainee characteristics and the probability of successfully passing classroom IGA test | 5 days | |
Secondary | Trainee characteristics | Association (reported as proportions, unadjusted and adjusted odds ratios) between trainee characteristics and the probability of successfully passing the field IGA test | 5 days | |
Secondary | Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based training. | Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of app versus slide-based training. | 45 minutes | |
Secondary | Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based IGA testing. | Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of app versus slide-based IGA testing. | 45 minutes | |
Secondary | Cost of app versus slide-based training | Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of app versus slide-based training | 5 days | |
Secondary | Cost of app versus slide-based IGA testing | Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of app versus slide-based IGA testing | 5 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03676140 -
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
|
Phase 3 | |
Completed |
NCT01949454 -
Fluorometholone as Ancillary Therapy for TT Surgery
|
N/A | |
Completed |
NCT01202331 -
Tripartite International Research for the Elimination of Trachoma
|
Phase 4 | |
Completed |
NCT05634759 -
Enhancing the A in SAFE for Trachoma
|
Phase 4 | |
Recruiting |
NCT04185402 -
Azithromycin Reduction to Reach Elimination of Trachoma
|
Phase 4 | |
Active, not recruiting |
NCT00886015 -
Modified Instrumentation for Surgery to Correct Trichiasis
|
Phase 3 | |
Completed |
NCT00792922 -
Partnership for Rapid Elimination of Trachoma
|
Phase 4 | |
Completed |
NCT00522860 -
A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery
|
Phase 4 | |
Completed |
NCT00221364 -
Trachoma Elimination Follow-up
|
Phase 4 | |
Completed |
NCT00322972 -
Trachoma Amelioration in Northern Amhara (TANA)
|
Phase 4 | |
Withdrawn |
NCT00286026 -
Azithromycin in Control of Trachoma II
|
Phase 4 | |
Completed |
NCT00347763 -
Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania
|
Phase 4 | |
Terminated |
NCT03997487 -
Smartphone App for Taking Images of Conjunctivae
|
N/A | |
Not yet recruiting |
NCT06289647 -
Azithromycin Reduction to Reach Elimination of Trachoma B
|
Phase 4 | |
Withdrawn |
NCT02655432 -
Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
|
Phase 0 | |
Completed |
NCT01767506 -
A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
|
N/A | |
Completed |
NCT00618449 -
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
|
Phase 4 | |
Completed |
NCT00356720 -
Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma
|
Phase 3 | |
Completed |
NCT03813069 -
Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma
|
Phase 2 | |
Recruiting |
NCT03335072 -
Kebele Elimination of Trachoma for Ocular Health
|
Phase 4 |